Navigation Links
Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference
Date:11/25/2008

RICHMOND, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic development programs and an overview of the company's business strategy at 4:30 pm (ET) on Tuesday, December 2, 2008 at the Piper Jaffray 20th Annual Health Care Conference in New York. The company will also update the financial community on its latest developments in its therapeutic programs and discuss other business matters at its annual Investor and Analyst Briefing to be held from 4:30 to 6:30 pm ET, on Wednesday, December 3, 2008.

The presentations will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentations will be archived on the Sangamo website for two weeks after the events.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy and ALS. Other therapeutic development programs are focused on cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, co
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
2. Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
3. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
4. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
5. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
6. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
7. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
8. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
9. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
10. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
11. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ING VALLEY, Calif., Nov. 6 Calbiot... a Small Business Innovative Research (SBIR) Phase...Material command. Under terms of the agreement, Ca...SRs) for the diagnosis of Dengue virus. ,, D...resents a major threat to military forces deployed...
(Date:11/6/2009)... The agenda for Arrowhead’s ..., which is set to take place on February 22-24, 20...ree day conference we will highlight key issues in... to share their experiences. , ...The agenda for Arrowhead’s 2010 Personalize...
(Date:11/5/2009)...LINGTON, Colo., Nov. 5 The endange... in the western U.S. This rare carnivore feeds on...ible to plague and often entire population die-off...rvice (FWS) has implemented a ferret breeding prog...s into their formerly native habitat. Unfortunate...
(Date:11/5/2009)...CHO CORDOVA, Calif., Nov. 5 /PRNewswire-FirstCall/...g supplier of innovative products for processing a...s for the first quarter of fiscal 2010. ,, For ...reported revenues of $5.2 million, a 15 percent in...quarter a year ago. The Company said the key contr...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...re plc,(LSE: SHP, NASDAQ: SHPGY), the global speci...as successfully settled all pending litigation in,...Transkaryotic Therapies,Inc. (TKT). Shire will pay...d to all TKT shareholders at the time of the July ...tigation, As previously disclosed, before complet...
...Board:,VYTC) today announced that it has reached a...n against BIOAGRA, LLC. Pursuant to the terms of t... ownership interest in,BIOAGRA, LLC, and Paul H. M...he sole Manager, and only executive officer of BIO...a Form 8-K filed today with the Securities,and Exc...
...Tectonics Corporation,s (Amex: ETC ) ("ETC" or th...hired Mr. David Steimle as Director of Business,De...g market awareness for,the BARA-MED(R) XD Monoplac... of a time proven computerized monoplace hyperbari...ears in the medical industry,twelve of them within...
Other Biology Technology:Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation 2Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation 3Vyta Corp Acquires 100% Ownership of BIOAGRA, LLC 2Environmental Tectonics Corporation Announces Staff Addition to Its BioMedical Systems Division 2Environmental Tectonics Corporation Announces Staff Addition to Its BioMedical Systems Division 3
(Date:11/9/2009)...er 09, 2009 / b3c newswire / - Today, TNO, a Du...ve, an American organization for contract research... signed a letter of intent with regard to TNOs dyn...etter of intent proposes a collaboration in which ...rcialization in North America. The TIM systems wil...
(Date:11/8/2009)...earchers at Purdue University have discovered a ne...pinal cord injuries using nano-spheres that could ...nt. , The synthetic "copolymer micelles" are dru..., or roughly 100 times smaller than the diameter o...ying how to deliver drugs for cancer treatment and...
(Date:11/6/2009)...rsary this month of the publication of On the Orig...l Sciences (AIBS) is publishing open access two pe...historic insights into evolution. , The two artic...ornia, Berkeley, and James T. Costa of Western Car...ut Charles Darwin," appeared in the October issue ...
Breaking Biology News(10 mins):TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3American Academy of Physician Assistants Applauds Senate Finance Committee for Advancing Health Reform Legislation 59488 1American Academy of Physician Assistants Applauds Senate Finance Committee for Advancing Health Reform Legislation 59488 2PEAK Surgical Announces Results of First PRECISE Studies at American College of Surgeons Clinical Congress 5492 1PEAK Surgical Announces Results of First PRECISE Studies at American College of Surgeons Clinical Congress 5492 2PEAK Surgical Announces Results of First PRECISE Studies at American College of Surgeons Clinical Congress 5492 3Quicker Referral for Gallbladder Operation Could Save 50 Percent of Preoperative Treatment Charges 59481 1Quicker Referral for Gallbladder Operation Could Save 50 Percent of Preoperative Treatment Charges 59481 2Quicker Referral for Gallbladder Operation Could Save 50 Percent of Preoperative Treatment Charges 59481 3
...r-old human remains found in France suggests that ...ier than scientists once thought. , Cédric Beauva...nce, Max Planck Institute in Germany, and Washingt...n femur fragment found in 2002 in the cave of the ...ed on its shape and mitochondrial DNA. Its age pla...
...over a quarter of a million people in Southeast As... from the media, but the event is nevertheless hea...ectly involved. In the aftermath of the disaster, ...stigate how the number of casualties could have be...mage can be avoided if a tsunami ever strikes agai...
...three molecules –?from a search of 58,000 compound...zheimer,s disease. , Each of the three molecules p...pelessly tangled in the brains of patients with Al...evelopment of drugs for the disease. , Ken Kosik,...e at the University of California, Santa Barbara, ...
Other Biology News:Neandertal femur suggests competition with hyenas and a shift in landscape use 2Stem Cells to Solve the Blood Shortage Problem? 2Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels 2Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels 3
Nar I from Promega
Chicken Anti-UCK2 Polyclonal Antibody, Unconjugated from Abcam
...nant Enterokinase (rEK) is a highly purified prepa...nase, a serine protease which recognizes the ident...AspLys↓) and has similar enzymatic activity. ...ified to yield the highest activity available, and...
Enterokinase from bovine intestine from Sigma-Aldrich
Biology Products: